相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Structural Features of Novel Bacterial Topoisomerase InhibitorsThat Define Their Activity on Topoisomerase IV
Maja Kokot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
A Short History of Topoisomerase Inhibitors at Actelion Pharmaceuticals
Cornelia Zumbrunn
CHIMIA (2022)
Novel Bacterial Topoisomerase inhibitors (NBTIs) - A comprehensive review
Jigar Desai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS (2021)
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs)
Anja Kolaric et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Pyrido[2,3-b]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV
Yimin Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics
Michelle F. Richter et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase
Elizabeth G. Gibson et al.
ACS INFECTIOUS DISEASES (2019)
Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens
Gabriele Magaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Machine learning-powered antibiotics phenotypic drug discovery
Sannah Zoffmann et al.
SCIENTIFIC REPORTS (2019)
Novel bacterial topoisomerase inhibitors: challenges and perspectives in reducing hERG toxicity
Anja Kolaric et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria
Jean-Philippe Surivet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Targeting bacterial topoisomerases: how to counter mechanisms of resistance
Yuk-Ching Tse-Dinh
FUTURE MEDICINAL CHEMISTRY (2016)
A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
Gregory S. Bisacchi et al.
ACS INFECTIOUS DISEASES (2015)
NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-negative Bacteria and In Vivo Efficacy
Thomas J. Dougherty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Prospects for Developing New Antibacterials Targeting Bacterial Type IIA Topoisomerases
Tihomir Tomašić et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Clinical relevance of the ESKAPE pathogens
Jack N. Pendleton et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Challenges of Antibacterial Discovery
Lynn L. Silver
CLINICAL MICROBIOLOGY REVIEWS (2011)
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Benjamin D. Bax et al.
NATURE (2010)
Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases
Michael T. Black et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)